Commit To Purchase BioCryst Pharmaceuticals At $4, Earn 68.9% Annualized Using Options
October 25, 2016 at 11:48 AM EDT
Investors eyeing a purchase of BioCryst Pharmaceuticals, Inc. (BCRX) shares, but cautious about paying the going market price of $4.61/share, might benefit from considering selling puts among the alternative strategies at their disposal..